Detalles de la búsqueda
1.
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.
Blood
; 141(23): 2841-2852, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36877894
2.
Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival.
Front Oncol
; 13: 1271807, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111533
3.
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
Blood Cancer J
; 12(12): 171, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535935
Resultados
1 -
3
de 3
1
Próxima >
>>